JPH07155177A - Method for deactivating virus - Google Patents

Method for deactivating virus

Info

Publication number
JPH07155177A
JPH07155177A JP34266793A JP34266793A JPH07155177A JP H07155177 A JPH07155177 A JP H07155177A JP 34266793 A JP34266793 A JP 34266793A JP 34266793 A JP34266793 A JP 34266793A JP H07155177 A JPH07155177 A JP H07155177A
Authority
JP
Japan
Prior art keywords
blood
cells
virus
plasma
plasma components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP34266793A
Other languages
Japanese (ja)
Inventor
Yoshiaki Nagaura
善昭 長浦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP34266793A priority Critical patent/JPH07155177A/en
Publication of JPH07155177A publication Critical patent/JPH07155177A/en
Pending legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PURPOSE:To kill or deaetivate microbes such as bacteria or virus existing in the blood, plasma components and other solutions. CONSTITUTION:The blood is taken out of the body and subjected to a centrifugal separator 5 to separate it into cells such as erythrocyte, leukocyte and blood platelet and plasma components to transfer the virus in the blood into the plasma components, which are then fed, via a connecting tube 6, to a vessel 1. Using an ultrasonic wave oscillating section 3 set up inside the vessel 1, ultrasonic waves are given into the plasma components to treat them physically and deactivate the virus in the plasma components. The resultant plasma components and a solution containing the aforementioned cells separated by the centrifugal separator 5 are fed, via connecting tubes 7 and 8, into a mixer 9, respectively, where the plasma components and the cells are put together.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、血液、血漿成分及びそ
の他の溶液中に存在する細菌及びウイルス等の微生物を
殺菌及び不活化するのに必要な技術に関するものであ
る。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a technique necessary for sterilizing and inactivating microorganisms such as bacteria and viruses existing in blood, plasma components and other solutions.

【0002】[0002]

【従来の技術】従来、ウイルスを不活化及び抑圧する方
法としては、ワクチン及び薬物等を使用して、ウイルス
を不活化及び抑圧しているけれども、HIVウイルス及
び肝炎ウイルス及び発癌性ウイルス等のウイルスに対し
ては、今のところ、有効な治療方法は確立していないの
が現状である。
2. Description of the Related Art Conventionally, as a method for inactivating and suppressing viruses, vaccines and drugs have been used to inactivate and suppress viruses, but viruses such as HIV virus, hepatitis virus and carcinogenic virus have been used. However, at present, no effective treatment method has been established.

【0003】[0003]

【発明が解決しようとする課題】血液、血漿成分及びそ
の他の溶液中に存在する細菌及びウイルス等の微生物を
殺菌及び不活化することを目的とする。
It is an object of the present invention to kill and inactivate microorganisms such as bacteria and viruses existing in blood, plasma components and other solutions.

【0004】[0004]

【課題を解決するための手段】図1は本発明の原理説明
図で、図1は縦断面図で、図中、1はガラス又はプラス
チック等でできた容器で、2は超音波を発振する装置
で、3は超音波を発振する発振部分で、4はゴムで出来
た接合部分である。
FIG. 1 is an explanatory view of the principle of the present invention. FIG. 1 is a longitudinal sectional view, in which 1 is a container made of glass or plastic and 2 is an ultrasonic wave. In the apparatus, 3 is an oscillating portion that oscillates ultrasonic waves, and 4 is a joining portion made of rubber.

【0005】[0005]

【作用】人体の血液を体外に導き出して、体外循環させ
ている血液を、赤血球、白血球及び血小板等の細胞と血
漿成分とに、血液を遠心分離器5を使用して分離する
と、例えば、血液中に存在するフリー状態のHIVウイ
ルスは、サイズが極小さい200nmなので、血液中に
存在するフリー状態のHIVウイルスは、血液を分離す
ることにより、大多数は血漿成分中に移動することにな
る。
When the blood of the human body is drawn out of the body and the blood circulating in the body is separated into cells such as red blood cells, white blood cells and platelets and plasma components using the centrifuge 5, for example, blood Since the free HIV virus present therein has a very small size of 200 nm, the majority of the free HIV virus present in blood will be transferred to the plasma component by separating the blood.

【0006】血液中の重要な細胞である、赤血球、白血
球及び血小板等の細胞は超音波の物理的な圧力波に弱
く、すぐに破壊されるので、全てを含んだ血液に超音波
をかけることには問題点があるので、超音波に弱い赤血
球、白血球及び血小板等の細胞と、液状蛋白質等の蛋白
質の成分で、比較的に超音波に強い、血漿成分に分離し
た後、血液中に存在する、フリー状態のHIVウイルス
の大多数を、血漿成分中に移動させ、血液中よりフリー
状態のHIVウイルスを移動させた、血漿成分中に超音
波をかけることにより血漿成分を破壊することなく、血
漿成分中に存在する、フリー状態のHIVの1部分であ
るエンベロープ部分又はHIVウイルスの全部を、超音
波の物理的な空洞現象を利用して、HIVウイルスを破
壊し、HIVウイルスを不活化することができる現象を
利用する。
Since important cells in blood, such as red blood cells, white blood cells and platelets, are vulnerable to physical pressure waves of ultrasonic waves and are quickly destroyed, ultrasonic waves should be applied to all blood. Since it has a problem with erythrocytes, it is present in blood after being separated into cells such as red blood cells, white blood cells and platelets, which are weak against ultrasonic waves, and protein components such as liquid proteins, which are relatively strong against ultrasonic waves, and plasma components. The majority of the HIV virus in the free state is moved into the plasma component, and the HIV virus in the free state is moved from the blood, without destroying the plasma component by applying ultrasonic waves to the plasma component, Using the physical cavity phenomenon of ultrasonic waves, the HIV virus is destroyed in the envelope part, which is one part of HIV in a free state, or the entire HIV virus, which is present in plasma components. The use of the phenomenon that can be inactivated.

【0007】超音波を使用して、血漿成分中に存在する
フリー状態のHIVウイルスを不活化し、血漿成分中に
存在したHIVウイルスを除去したあとの血漿成分と、
遠心分離器5にて分離した赤血球、白血球及び血小板等
の細胞を合体させて一緒にし、人体に還流させることに
より、超音波の物理的な空洞現象に弱い赤血球、白血球
及び血小板を損傷することなく、血液中のHIVウイル
スの数値を低下させることができる。
Plasma components after inactivation of free HIV virus present in plasma components using ultrasonic waves and removal of HIV viruses present in plasma components,
Cells such as erythrocytes, leukocytes, and platelets separated by the centrifuge 5 are combined and put together and refluxed to the human body without damaging erythrocytes, leukocytes, and platelets that are vulnerable to the physical cavity phenomenon of ultrasonic waves. , It can reduce the number of HIV virus in the blood.

【0008】血液中の重要な細胞である、赤血球、白血
球及び血小板等の細胞を、破壊しない範囲の、超音波の
物理的な破壊力を利用して、白血球等の、表面上に非共
有結合している、HIVウイルス等のウイルスだけを選
択的に共振させ、感染細胞の表面上に非共有結合してい
る、HIVウイルスを、超音波の物理的な圧力波の破壊
力である、空洞現象を利用して、強制的に、振飛ばし
て、感染細胞の表面上より分離し、血液中に離脱させて
溶解させた後、血液を遠心分離器5にかけて、赤血球、
白血球及び血小板等の細胞と血漿成分に分離し、血液中
のHIVウイルス等のウイルスを血漿成分に移動させ、
HIVウイルス等のウイルスが溶解している、血漿成分
中に超音波をかけて物理的に処理し、血漿成分中のHI
Vウイルスを不活化することにより、超音波の破壊力に
弱い赤血球、白血球及び血小板等の細胞を損傷すること
なく、細胞の表面上に非共有結合しているHIVウイル
ス等のウイルスを間接的に不活化することが出来ること
になる。
Non-covalent binding of leukocytes, etc. on the surface by utilizing the physical destructive force of ultrasonic waves to the extent that important cells in blood, such as erythrocytes, leukocytes and platelets, are not destroyed. Cavity phenomenon, which is the destructive force of the ultrasonic physical pressure wave, is caused by selectively resonating only viruses such as HIV virus and non-covalently binding on the surface of infected cells. , The cells are forcibly shaken, separated from the surface of the infected cells, separated into the blood and lysed, and then the blood is centrifuged to remove red blood cells,
Separation into cells such as white blood cells and platelets and plasma components, transfer of viruses such as HIV virus in blood to plasma components,
The HI in the plasma component is treated by applying ultrasonic waves to the plasma component in which a virus such as HIV virus is dissolved
By inactivating the V virus, the virus such as the HIV virus that is non-covalently bound to the surface of the cell is indirectly bonded without damaging the cells such as red blood cells, white blood cells, and platelets, which are weak against ultrasonic destructive power. It can be inactivated.

【0009】[0009]

【実施例】 以下、図2に関連して本発明の実施例を説
明する。図2は本例の実施例のウイルスを不活化する手
段を示す構造概要説明図で、図2は縦断面図で、図中、
1はガラスまたはプラスチック等で出来た容器で、2は
超音波を発振する装置で、3は超音波を発振する発振部
分で、4はゴム等でできた接合部分で、5は遠心分離器
で、6、7及び8は接続管である。
EXAMPLE An example of the present invention will be described below with reference to FIG. FIG. 2 is a structural schematic explanatory view showing a means for inactivating a virus according to the embodiment of the present invention, and FIG. 2 is a vertical cross-sectional view.
1 is a container made of glass or plastic or the like, 2 is a device for oscillating ultrasonic waves, 3 is an oscillating part for oscillating ultrasonic waves, 4 is a joining part made of rubber or the like, and 5 is a centrifuge. , 6, 7 and 8 are connecting pipes.

【0010】図2にて図示しているのは、人体の血液を
体外に導き出して、体外に導き出した血液を、遠心分離
器5を使用して、血液中の成分である、赤血球、白血球
及び血小板等と血漿成分に分離すると、HIVウイルス
は、直径が200nmと、極く小さいので、血漿成分中
に移動する、遠心分離器5を使用して血漿成分中に移動
させ、HIVウイルスが混入している血漿成分を、接続
管6を使用して、容器1内部に送り、容器1内部に設け
ている、超音波の発振部分3を使用して、容器1内部に
於て、血漿成分に超音波を連続的にかけ、血漿成分中に
存在している、HIVウイルスの一部分又は全部を物理
的に破壊して、血漿成分中のHIVウイルスを不活化
し、血漿成分中のHIVウイルスを物理的に除去したあ
との血漿成分を、接続管8を使用して、混合器9に送
り、混合器9内部に於て、遠心分離器5にて分離した赤
血球、白血球及び血小板等の細胞を含有している溶液
を、遠心分離器5より接続管7を経由して、混合器9に
送り込み、血漿成分中のHIVウイルスを不活化して、
血漿成分中よりHIVウイルスを除去した血漿成分と
を、混合器9内部に於て合流させて一緒にした後、人体
に還流している状態を示している。
FIG. 2 shows that the blood of the human body is drawn out of the body, and the blood drawn out of the body is subjected to a centrifuge 5 to collect red blood cells, white blood cells and white blood cells, which are components in the blood. When separated into platelets and plasma components, the HIV virus has a very small diameter of 200 nm, so it moves into the plasma components. It is transferred into the plasma components using the centrifuge 5, and the HIV virus is contaminated. The plasma component present in the container 1 is sent to the inside of the container 1 using the connecting pipe 6, and the ultrasonic wave oscillating portion 3 provided inside the container 1 is used to convert the plasma component into the inside of the container 1. A sound wave is continuously applied to physically destroy a part or all of the HIV virus present in the plasma component, inactivate the HIV virus in the plasma component, and physically destroy the HIV virus in the plasma component. After removing the plasma component, The solution containing the cells such as red blood cells, white blood cells and platelets separated by the centrifuge 5 in the mixer 9 is sent from the centrifuge 5 to the mixer 9 using the tube 8. It is sent to the mixer 9 via the connecting pipe 7 to inactivate the HIV virus in the plasma component,
The plasma component obtained by removing the HIV virus from the plasma component is merged in the inside of the mixer 9 to be combined, and then the plasma component is refluxed to the human body.

【0011】[0011]

【発明の効果】血液を体外に導き出して、体外に導き出
した血液を遠心分離器にかけて、超音波の物理的な破壊
力に弱い、赤血球、白血球及び血小板等の細胞と、超音
波の物理的な破壊力に強い血漿成分とに遠心分離器を使
用して分離し、血液中に存在する、大多数のフリー状態
のHIVウイルスを血漿成分の内部に移動させ、血漿成
分中に移動したHIVウイルスを、血漿成分に損傷を与
えることなく、血漿成分中に存在するHIVウイルスを
超音波を使用して不活化した後、遠心分離器にて分離し
た赤血球、白血球及び血小板等の細胞と、血漿成分を合
流させて一緒にし、人体に還流させることで、超音波の
物理的な破壊力に弱い赤血球、白血球及び血小板等の細
胞を損傷することなく、血液中に存在するフリー状態の
HIVウイルスを不活化することが出来ることにより、
血液中のHIVウイルスの数値を低下させることで、エ
イズの発症を遅延させることが出来る、治療手段として
の効果がある。
EFFECTS OF THE INVENTION Blood is drawn out of the body, and the blood drawn out of the body is subjected to a centrifuge, and cells such as red blood cells, white blood cells and platelets, which are weak against the physical destructive force of ultrasonic waves, and ultrasonic physical waves. Centrifugal separation is used to separate the plasma components that are highly destructive, and the majority of free HIV viruses present in the blood are transferred to the inside of the plasma components, and the HIV viruses that have migrated to the plasma components are separated. After inactivating the HIV virus present in the plasma component using ultrasonic waves without damaging the plasma component, cells such as red blood cells, white blood cells and platelets separated by a centrifuge and the plasma component are separated. By merging, bringing together and returning to the human body, the HIV virus in the free state existing in the blood is damaged without damaging cells such as red blood cells, white blood cells and platelets, which are weak against the physical destructive power of ultrasonic waves. By that can be inactivated,
By lowering the HIV virus level in the blood, it is possible to delay the onset of AIDS, which is effective as a therapeutic means.

【0012】当考案の治療手段は、人体の体内よりHI
Vウイルス等のウイルスを完全に撲滅することは出来な
いけれども、超音波の物理的な破壊力を使用して、HI
Vウイルス等のウイルスを破壊するので、HIVウイル
ス以外の、あらゆるウイルスを不活化することが出来る
ことにより、あらゆるウイルス性疾患の治療手段とし
て、当考案の治療手段を利用することが出来ることと、
当考案の治療手段は、副作用等の弊害が、全く発生しな
いので、種々雑々なウイルス性疾患に応用することが出
来る、治療手段として利用することが出来る効果があ
る。
[0012] The therapeutic means of the present invention is designed so that the HI
Although it is not possible to completely eradicate viruses such as V virus, HI is used by using the physical destructive power of ultrasonic waves.
Since a virus such as V virus is destroyed, any virus other than HIV virus can be inactivated, and thus the therapeutic means of the present invention can be used as a therapeutic means for all viral diseases.
Since the therapeutic means of the present invention causes no adverse effects such as side effects at all, it has an effect that it can be used as a therapeutic means that can be applied to various and various viral diseases.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明の原理説明図で、図1は縦断面図であ
る。
FIG. 1 is an explanatory view of the principle of the present invention, and FIG. 1 is a vertical sectional view.

【図2】本発明の実施例のウイルスを不活化する手段を
示す構造概要説明図で、図2は縦断面図である。
FIG. 2 is a schematic structural explanatory view showing a means for inactivating a virus according to an embodiment of the present invention, and FIG. 2 is a vertical sectional view.

【符号の説明】[Explanation of symbols]

1.ガラス又はプラスチック等で出来た容器(略して、
容器とする) 2.超音波を発振する装置 3.超音波を発振する発振部分(略して、発振部分とす
る) 4.ゴム等で出来た接合部分 5.遠心分離器 6.7及び8.接続管
1. A container made of glass or plastic (abbreviated as
Make a container) 2. Device that oscillates ultrasonic waves 3. 3. Oscillation part that oscillates ultrasonic waves (abbreviated as oscillation part) 4. Joint part made of rubber etc. 5. Centrifuge 6.7 and 8. Connecting pipe

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 血液中又は血漿成分中に存在する、HI
Vウイルス等のウイルスを不活化するのに、血液又は血
漿成分に超音波をかけて処理し、超音波の物理的圧力波
の破壊力を利用して、血液中又は血漿成分に存在するウ
イルスを不活化する方法。
1. HI present in blood or plasma components
In order to inactivate viruses such as V virus, ultrasonic treatment is applied to blood or plasma components, and viruses existing in blood or plasma components are utilized by utilizing the destructive force of physical pressure waves of ultrasonic waves. How to inactivate.
【請求項2】 人体の体外に血液を導き出して、体外循
環している血液又は血漿成分に、超音波をかけて処理
し、血液又は血漿成分中のHIVウイルス等のウイルス
を不活化する請求項(1)記載のウイルスを不活化する
方法。
2. A method of inducing blood out of the human body and inactivating blood or plasma components circulating in the body by applying ultrasonic waves to inactivate viruses such as HIV virus in the blood or plasma components. (1) A method for inactivating the virus according to (1).
【請求項3】 人体の体外に血液を導き出して、血液を
遠心分離器(5)にかけて、赤血球、白血球及び血小板
等の細胞と、血漿成分に分離し、血液中に存在している
HIVウイルス等のウイルスを血漿成分中に移動させ、
血液中のウイルスが移動した血漿成分を、接続管(6)
を使用して、容器(1)に送り、容器(1)内部に設け
ている、超音波の発振部分(3)を使用して、血漿成分
中に超音波を発振して物理的に処理し、血漿成分中のウ
イルスを不活化し、血漿成分中のウイルスを不活化した
血漿成分と、遠心分離器(5)にて分離した、赤血球、
白血球及び血小板等の細胞を含有している溶液を、接続
管(7)及び(8)を使用して、それぞれ混合器(9)
に送り、混合器(9)内部にて、血漿成分中に存在する
ウイルスを不活化した血漿成分と、赤血球、白血球及び
血小板等の細胞とを合流させて一緒にし、人体に還流す
る請求項(1)及び(2)記載のウイルスを不活化する
方法。
3. The HIV virus or the like existing in the blood is drawn out of the human body, and the blood is centrifuged to separate it into cells such as red blood cells, white blood cells and platelets and plasma components. Virus in the blood plasma component,
Connect the plasma component in which the virus in the blood is transferred to the connecting pipe (6)
Is sent to the container (1), and the ultrasonic wave oscillating portion (3) provided inside the container (1) is used to oscillate ultrasonic waves into the plasma component for physical treatment. A red blood cell separated by a centrifuge (5) from a plasma component in which the virus in the plasma component has been inactivated and the virus in the plasma component has been inactivated,
A solution containing cells such as white blood cells and platelets is mixed using a connecting pipe (7) and (8), respectively, into a mixer (9).
The plasma component in which the virus present in the plasma component is inactivated and the cells such as red blood cells, white blood cells and platelets are merged and mixed in the mixer (9) and then refluxed to the human body. A method for inactivating the virus according to 1) or 2).
【請求項4】 人体の体外に血液を導き出して、体外循
環させている血液中に、赤血球、白血球及び血漿板等の
細胞を、破壊しない範囲の、超音波をかけて血液を処理
し、白血球等の細胞の表面上に、細胞と非共有結合して
いるHIVウイルス等の、ウイルスを白血球等の、細胞
の表面上より剥離又は振飛ばして、血液中に離脱させる
請求項(1)、(2)及び(3)記載のウイルスを不活
化する方法。
4. Leukocytes are obtained by treating the blood by irradiating the blood outside the body of the human body with ultrasonic waves to the extent that the cells such as red blood cells, white blood cells and plasma plates are not destroyed in the extracorporeally circulating blood. (1), wherein the virus such as HIV virus which is non-covalently bound to the cell on the surface of the cell such as the above is detached or shaken from the surface of the cell such as the white blood cell and the like to be released into the blood. A method for inactivating the virus according to 2) and 3).
【請求項5】人体の体外に血液を導き出して、体外循環
させている血液中に、赤血球、白血球及び血小板等の細
胞を、破壊しない範囲内の、超音波をかけて血液を処理
し、白血球等の細胞の表面上に、細胞と非共有結合して
いるHIVウイルス等の、ウイルスを白血球等の、細胞
の表面上より剥離又は振飛ばして、血液中に離脱させた
後、血液を遠心分離器(5)にかけて、細胞部分と血漿
成分に分離し、血漿成分中に超音波をかけて処理し、血
漿成分中のHIVウイルス等のウイルスを不活化して、
人体に還流する請求項(1)、(2)、(3)及び
(4)記載のウイルスを不活化する方法。
5. Leukocytes are obtained by treating the blood by applying ultrasonic waves within a range that does not destroy cells such as red blood cells, white blood cells and platelets in the blood that is circulated outside the human body by circulating the blood outside the human body. After separating or shaking the virus, such as HIV virus, which is non-covalently bound to the cells, such as white blood cells, from the surface of the cells, such as white blood cells, and separating them into the blood, centrifuge the blood. In a vessel (5), the cells and plasma components are separated, and the plasma components are sonicated to inactivate viruses such as HIV virus in the plasma components,
A method for inactivating the virus according to any one of claims (1), (2), (3) and (4) which is refluxed to the human body.
JP34266793A 1993-12-03 1993-12-03 Method for deactivating virus Pending JPH07155177A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP34266793A JPH07155177A (en) 1993-12-03 1993-12-03 Method for deactivating virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34266793A JPH07155177A (en) 1993-12-03 1993-12-03 Method for deactivating virus

Publications (1)

Publication Number Publication Date
JPH07155177A true JPH07155177A (en) 1995-06-20

Family

ID=18355563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP34266793A Pending JPH07155177A (en) 1993-12-03 1993-12-03 Method for deactivating virus

Country Status (1)

Country Link
JP (1) JPH07155177A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576201B1 (en) 2000-01-28 2003-06-10 Baxter International Inc. Device and method for pathogen inactivation of therapeutic fluids with sterilizing radiation
US6596230B1 (en) 2000-01-28 2003-07-22 Baxter International Inc. Device and method for pathogen inactivation of therapeutic fluids with sterilizing radiation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576201B1 (en) 2000-01-28 2003-06-10 Baxter International Inc. Device and method for pathogen inactivation of therapeutic fluids with sterilizing radiation
US6596230B1 (en) 2000-01-28 2003-07-22 Baxter International Inc. Device and method for pathogen inactivation of therapeutic fluids with sterilizing radiation

Similar Documents

Publication Publication Date Title
US7118852B2 (en) Methods and apparatus for decontaminating fluids
US9375525B2 (en) Modular extracorporeal systems and methods for treating blood-borne diseases
US20130012927A1 (en) Selective lysing of cells using ultrasound
ATE54828T1 (en) TREATMENT OF BIOLOGICAL AND PHARMACEUTICAL PRODUCTS ADOPTED ON A SOLID PHASE WITH VIRAL AND PYROGENIC INACTIVATING AGENTS.
WO2002072236A1 (en) Particle separation
US20160250407A1 (en) Modular Extracorporeal Systems and Methods for Treating Blood-Borne Diseases
JPH0660105B2 (en) Method for inactivating hepatitis virus in plasma
DE3379644D1 (en) Adsorbent and process for preparing the same
US5628727A (en) Extracorporeal virioncidal apparatus
CA2693293A1 (en) Method and bag set for concentrating white cells
JP2004514680A5 (en)
NO316989B1 (en) Plasma treatment systems
AU2002306757B2 (en) Methods and apparatus for decontaminating fluids
FR2651438A1 (en) METHOD OF ULTRASOUND INACTIVATION OF INFECTIOUS OR PARASITIC AGENTS IN BIOLOGICAL MEDIA AND APPLICATIONS OF THE PROCESS
JPH07155177A (en) Method for deactivating virus
US2230997A (en) Method of extracting constituents of living cells
Matthews et al. Preliminary studies of photoinactivation of human immunodeficiency virus in blood
JP2002527149A5 (en)
JPH06183998A (en) Method for treating body fluid-related disease, device therefor and medicine for the same
Mino et al. Meshless bubble filter using ultrasound for extracorporeal circulation and its effect on blood
JPH0847528A (en) Device for deactiviating or decreasing bacteria or virus and the like existing in human blood
JPH03188872A (en) Method for deactivating aids virus
JP2000152986A (en) Method of inactivating viruses
RU2076743C1 (en) Method for performing plasmophoresis treatment
SU1386169A1 (en) Method of separating the eggs of opistorchis